SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.170
-0.100 (-3.06%)
Nov 20, 2024, 4:00 PM EST - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $210.61 million as of November 21, 2024. Its market cap has decreased by -16.10% in one year.
Market Cap
210.61M
Enterprise Value
146.50M
1-Year Change
-16.10%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $210.61M, a decrease of -81.20%. That is a compound annual growth rate of -39.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 217.25M | -29.18% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Utah Medical Products | 219.40M |
| Genfit | 218.94M |
| MacroGenics | 218.42M |
| High Tide | 215.35M |
| Zentalis Pharmaceuticals | 213.08M |
| Personalis | 209.21M |
| Sera Prognostics | 208.71M |
| Inhibrx Biosciences | 206.86M |